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The ethanol extract from the fruits of Duguetia chrysocarpa was evaluated for its antinociceptive activity in chemical and thermal
models of nociception in mice. The intraperitoneal administration of the ethanol extract (100, 200, and 400mg/kg body weight)
showed a dose-dependent inhibition of acetic-acid-induced abdominal writhes. The extract also produced a signiﬁcant inhibition
of both phases of the formalin test in all doses tested and increased the reaction time in hot-plate test at dose of 200mg/kg. The
data obtained suggest that the antinociceptive eﬀect of the extract may be mediated via both peripheral and central mechanisms.
The phytochemical investigation yielded the isolation of the benzenoid derivative 3-methoxy-4-ethoxy benzoic acid which is being
reported for the ﬁrst time in this genus.
1.Introduction
Pain is a sensorial modality which in many cases represents
the only symptom for the diagnosis of several diseases. It
often has a protective function [1]. Pain is one of the most
pervasive problems in our society and has high social costs
due to the signiﬁcant impairment or permanent disabling
of millions of people. Pain can be deﬁned as an unpleasant
perception of a nociceptive sensation. This concept involves
2 components, nociception and perception. Pain perception
is an integrative function modulated by emotional, motiva-
tional,psychologicalconditionsandindividual’spasthistory.
Nociception or the nociceptive sensation results from the
activation of speciﬁc primary sensory neuron subpopula-
tions that transmit the nociceptive information to the spinal
cord from where it is relayed to supra spinal levels [2, 3].
In a general manner, there are four types of pain: (a)
nociceptive pain, due to excessive stimulation of nociceptors
localized in the skin, viscera, and other organs; (b) neu-
rogenic pain, pain reﬂecting damage to neuronal tissue in
the periphery or CNS; (c) neuropathic pain, due to a dys-
function of, or damage to, a nerve or group of nerves; (d)
psychogenic pain, not due to an identiﬁable, somatic origin
and which may reﬂect psychological factors. Pain is usually
elicited by the activation of speciﬁc nociceptors (nociceptive
pain). However, it may also result from injury to sensory
ﬁbres or from damage to the CNS itself (neuropathic pain)
[4].
Despite the progress that has occurred in recent years
in the development of pain therapy, there is still a need for
eﬀective and potent analgesics, especially for the treatment
of chronic pain [5]. Plant-derived substances have, and will
certainly continue to have, a relevant place in the process
of extract discovery, particularly in the development of new
analgesics [6].
The use of medicinal plants as analgesic and anti-in-
ﬂammatory drugs in folk medicine is a practice common in
manycountries,although,inmostcases,theactiveprinciples
of the plants are unknown. However, evaluation of the
pharmacological eﬀects of the herbal crude extracts can still2 The Scientiﬁc World Journal
be used as a logical research strategy for searching of new
drugs [7].
Annonaceae is a large family comprising ca. 135 genera
and 2500 species which are distributed mainly in tropical
and subtropical regions of the world [8]. Chemical studies
with species of this family have reported the isolation of ter-
penoids (mainly diterpenes), essential oils which the compo-
sitionispredominantlyofmonoterpenesandsesquiterpenes,
and alkaloids, especially isoquinoline alkaloids [9].
The genus Duguetia consists of approximately 80 known
species native to tropical America. Few chemical data are
available on this genus, despite the considerable number of
species. Several isoquinoline-derived alkaloids and sesquiter-
p e n e - t y p es t r u c t u r e sh a v eb e e nr e p o r t e d[ 10, 11]. Chemical
study realized with species of this genus by our group
showed the isolation of alkaloids and a new cinnamate de-
rivative from Duguetia gardneriana [12]. The chemical
composition and antimicrobial activity of the leaf essential
oilsofDuguetiagardnerianaandDuguetiamoricandianaalso
were evaluated [13]. Discretamine, an alkaloid isolated from
Duguetia moricandiana, demonstrated antinociceptive activ-
ity in experimental models [14]. In a recent study, we eval-
uated the phenolic quantiﬁcation and antioxidant activity of
Anaxagorea dolichocarpa and Duguetia chrysocarpa [15].
T h e r ei sn op r e v i o u sr e p o r to np h a r m a c o l o g i c a ls t u d i e s
of D. chrysocarpa. Thus, the aim of this study was to eval-
uate the antinociceptive eﬀect of ethanol extract from D.
chrysocarpa in experimental models of nociception.
2.MaterialsandMethods
2.1. Plant Material. T h ef r u i t so fDuguetia chrysocarpa Maas
were collected in Santa Rita, State of Paraiba, Brazil, in Jan-
uary 2004. A voucher specimen (AGRA 5538) was depos-
ited at the Herbarium Professor Lauro Pires Xavier (JPB), of
the Federal University of Paraiba.
2.2. Preparation of Plant Extract. The fruits of D. chrysocarpa
(2000g), dried and pulverized, were subjected to maceration
with 95% EtOH for 72 hours. The EtOH solution was
concentrated under vacuum yielding 107g of crude ethanol
extract of D. chrysocarpa (Dc-EtOH).
2.3. Preliminary Phytochemical Screening. Preliminary phy-
tochemical analysis of the extract was carried. The presence
of alkaloids was tested with Dragendorﬀ’s and Mayer’s
reagents, ﬂavonoids with HCl and Mg powder, phenols with
ferric chloride, and steroids and terpenoids by Liebermann-
Burchard reaction [16].
2.4. Animals. Male adult albino Swiss mice (35–40g) were
used throughout this study. The animals were randomly
housed in appropriate cages at 22 ± 2◦C on a 12h light/dark
cycle with free access to food and water. When necessary,
animals were deprived of food 12h prior to the experiments.
They were used in groups of six animals each. All noci-
ception tests were carried out by the same visual observer.
Experimentalprotocolsandprocedureswereapprovedbythe
Universidade Federal do Vale do S˜ ao Francisco Animal Care
and Use Committee by number 024240408.
2.5. Pharmacological Tests
2.5.1. Acetic-Acid-Induced Writhing Test. The test was per-
formed as described by Koster et al. [17] with modiﬁca-
tions. Mice were divided into six groups of six mice each
and pretreated with vehicle (saline), morphine (10mg/kg),
acetylsalicylic acid (ASA 150mg/kg), and Dc-EtOH (100,
200, and 400mg/kg) 30min before acetic acid injection
(0.9% v/v) i.p. in a volume of 0.1mL/10g. The number of
abdominal constrictions (full extension of both hind paws)
produced in each group for the succeeding 10min was
counted and compared to the response in the control group.
The antinociceptive activity was expressed as percentage of
inhibition of the abdominal constrictions.
2.5.2. Formalin Test. T h ef o r m a l i nt e s tw a sc a r r i e do u ta s
described by Hunskaar and Hole [18]. Vehicle (saline),
morphine (10mg/kg), acetylsalicylic acid (ASA 150mg/kg)
and Dc-EtOH (100, 200, and 400mg/kg) were administered
i.p. 60min before formalin injection. 20μL of 2.5% formalin
solution (0.92% formaldehyde) in 0.9% saline were injected
subcutaneously into the right hind paw of mice. Mice were
observed in the chambers with a mirror mounted on three
sides to allow view of the paws and the amount of time
(in seconds) that the animal spent licking the injected paw
was considered as an indicative of pain. Two distinct phases
of intensive licking activity were identiﬁed. Responses were
measured for 5min after formalin injection (ﬁrst phase,
neurogenic) and 15–30min after formalin injection (second
phase, inﬂammatory).
2.5.3. Hot Plate Test. In the hot-plate test, mice were pre-
selected on the hot plate at 55 ± 0.5◦C. Licks on the rear
paws were the parameters of observation. Animals showing
a reaction time (latency for licking the hind feet or jump-
ing) greater than 20s were discarded. The animals were
then treated with vehicle (saline, 0.1mL/10g), morphine
(10mg/kg), and Dc-EtOH (100, 200, and 400mg/kg) via i.p.
Thereactiontime (inseconds)foreachmicewasdetermined
on the hot plate during the maximum period of 20s, at
intervals of 30, 60, 90, and 120min after the administration
of the extract [19].
2.6. Statistical Analysis. A l ld a t aw e r ee x p r e s s e da sm e a n±
SEM. and the statistical signiﬁcance was determined using
ananalysisofvariance(ANOVA)followedbyDunnett’smul-
tiple comparison test. Values were considered signiﬁcantly
diﬀerent at P<0.05. All analysis was performed using
GraphPad Prism 4.0 program.
2.7. Isolation of a Compound from D. chrysocarpa. The
ethanol extract was acidiﬁed with 3% HCl and subjected to
extraction of alkaloids, obtaining a chloroform phase and
the fraction of total tertiary alkaloids. The chloroform phase
(3g)waschromatographedonsilicagelcolumninwhich255The Scientiﬁc World Journal 3
Table 1: Antinociceptive eﬀect of Dc-EtOH on acetic acid-induced
writhing in mice.
Group Dose (mg/kg) No. of
writhings % inhibition
Control — 17.80 ±2.29 —
Dc-EtOH
100 13.40±2.50∗∗ 24.72
200 6.60 ±2.54∗∗ 62.92
400 5.00 ±1.61∗∗ 71.92
Morphine 10 0.0 ±0.0∗∗ 100
Acetylsalicylic acid 150 2.17 ±0.87∗∗ 87.80
Values are mean ± SEM, n = 6. ∗∗P<0.01 signiﬁcantly diﬀerent from
control (ANOVA followed by Dunnett’s test).
fractions were obtained. These fractions were monitored by
TLC. The fraction 5-6, after analysis by TLC, was submitted
for spectral analysis of 1Ha n d13C NMR using one- and
two-dimensional methods. 1Ha n d13C-NMR spectra were
measured at 200MHz for 1Ha n d5 0 M H zf o r13C, using
CDCl3 as solvent and TMS as an internal standard.
3. Results
3.1.PreliminaryPhytochemicalScreening. Preliminaryanaly-
sis demonstrated that Dc-EtOH was found to be positive for
the presence of alkaloids, steroids, and terpenoids. However,
the ethanol extract was found to be negative for the presence
of ﬂavonoids.
3.2. Acetic-Acid-Induced Writhing Test. The intraperitoneal
administration of Dc-EtOH (100, 200, and 400mg/kg) had
a signiﬁcant eﬀect (P<0.01) on the number of writhing
induced by the i.p. administration of the acetic acid as
compared with control group treated with saline (Table 1).
The eﬀect was more signiﬁcant for morphine, which abo-
lished the abdominal writhings.
3.3. Formalin Test. Table 2 shows the results obtained with
the formalin test. During the ﬁrst phase (0–5min) and
second phase (15–30min), Dc-EtOH showed a signiﬁcant
reduction the licking activity in all doses tested.
3.4. Hot-Plate Test. In the hot-plate test, the animal treated
with ethanol extract of D. chrysocarpa at dose of 200mg/kg
modiﬁed the latency time 90 and 120min after the adminis-
tration of extract when compared with control animals (P<
0.05). The eﬀect of morphine (10mg/kg) was signiﬁcantly
higher (Table 3).
3.5. Structure Determination of a Compound Isolated from
D. chrysocarpa. The analysis of all the spectral data for the
compound and comparison with values of literature led to
the determination of its structure as 3-methoxy-4-ethoxy
benzoic acid (1). This compound was isolated previously
from Angelica furcijuga [20] but described here for the ﬁrst
time in the genus Duguetia. The 1D and 2D NMR spectra
were also used to assign unambiguously the 1Ha n d13C
chemical shifts (Table 4).
4. Discussion
Pain is a sensorial modality, which in many cases represents
the only symptom for the diagnosis of several diseases, and
oftenhasa protective function. Throughout history, manhas
used many diﬀerent forms of therapy for the relief of pain,
and medicinal herbs are highlighted due to their popular use
[21].
In this study, we aimed to investigate the possible
antinociceptive eﬀect of fruits ethanol extract from Duguetia
chrysocarpa (Dc-EtOH) using chemical and thermal models
of nociception. The ﬁrst test to evaluate the antinociceptive
activity of Dc-EtOH was the writhing induced by acetic-acid,
which is used to screen for both peripherally and centrally
acting agents [19]. Dc-EtOH signiﬁcantly reduced in a
dose-dependent manner the acetic acid-induced writhing
in mice. Intraperitoneal injection of acetic acid produced
17.80 ± 2.29 writhes in the control group for 10min after
injection. The groups previously treated with 100, 200, and
400mg/kg of Dc-EtOH exhibited a signiﬁcant reduction
in the number of writhings of 24.72, 62.92, and 71.92%,
respectively. The results revealed that Dc-EtOH has a potent
antinociceptive activity in this method. Collier et al. [22]
postulated that the acetic acid acts indirectly by inducing the
release of endogenous mediators which stimulate the noci-
ceptive neurons sensitive to nonsteroidal anti-inﬂammatory
drugs (NSAIDs) and opioids. One possible mechanism of
antinociceptive activity of Dc-EtOH could be due to the
blockadeoftheeﬀectorthereleaseofendogenoussubstances
(arachidonic acid metabolites) that sensitize and activate
peripheral nociceptors. The result of this test, however, does
notascertainwhethertheantinociceptiveeﬀectwasmediated
by central or peripheral process [23].
In order to distinguish between the central and periph-
eral antinociceptive action, the formalin test was perform-
ed. Formalin is a noxious stimulus commonly used in ani-
mal behavioral experiments. The formalin test originally de-
scribed by Dubuisson and Dennis [24] (1977) consists of
a subcutaneous (s.c.) formalin injection into the rat hind
paw that produces a biphasic nociceptive response which is
responsive to many classes of analgesic drugs [18]. The typi-
cal time course of the behavioral and electrophysiological
responses to formalin consists of an early phase of short-
lasting response, followed by a continuous prolonged re-
sponse that mimics some features of postinjury pain in man
[25]. The initial response (phase 1) is initially attributed
to a direct algogenic eﬀect of formalin on the nociceptors,
whereas phase 2 is associated with the release of local endo-
genous mediators responsible for sensitization of primary
and spinal sensory neurons and subsequent activation of the
nociceptors [26]. In this experiment, Dc-EtOH decreased
the licking time in mice in both phases, suggesting that this
extract exerts its antinociceptive eﬀect by central mecha-
nisms. The extract at dose of 400mg/kg was more eﬀective in4 The Scientiﬁc World Journal
Table 2: Eﬀect of Dc-EtOH on formalin-induced pain in mice.
Group Dose (mg/kg)
First phase Second phase
Licking time (s) % inhibition Licking time (s) % inhibition
Control — 72.40 ±5.7 7—8 1 .17 ±4.32 —
Dc-EtOH
100 32.00 ±5.05∗∗ 55.80 57.83 ±5.82∗∗ 28.75
200 44.00 ±1.79∗∗ 39.22 62.80 ±4.12∗∗ 22.63
400 37.20 ±4.95∗∗ 48.62 8.83 ±3.03∗∗ 89.12
Morphine 10 9.80 ±4.72∗∗ 86.46 30.00 ±2.94∗∗ 63.04
Acetylsalicylic acid 150 22.40 ±3.11∗∗ 69.06 13.17 ±10.25∗∗ 83.77
Values are mean ± SEM, n = 6. ∗∗P<0.01 signiﬁcantly diﬀerent from control (ANOVA followed by Dunnett’s test).
Table 3: Eﬀe c to fD c - E t O Ho nh o t - p l a t et e s ti nm i c e .
Group Dose (mg/kg)
Latency time (s)
30min 60min 90min 120min
Control — 5.10 ± 1.10 7.90 ±1.50 5.30 ±0.20 5.40 ±0.60
Dc-EtOH
100 5.20 ± 1.34 6.20 ±1.02 5.40 ±0.87 5.80 ±1.02
200 5.00 ± 0.80 8.00 ±1.20 8.00 ±1.10∗ 9.40 ± 1.40∗
400 4.40 ± 0.40 5.70 ±1.10 5.40 ±0.80 6.10 ±0.80
Morphine 10 19.33±0.67∗∗ 18.00±1.23∗∗ 17.80±1.11∗∗ 14.80±0.86∗∗
Values are mean ± SEM, n = 6. ∗P<0,05; ∗∗P<0.01 signiﬁcantly diﬀerent from control (ANOVA followed by Dunnett’s test).
Table 4: 1H (200MHz) and 13C (50MHz) NMR data for 1 including results obtained by heteronuclear 2D shift-correlated HMQC and
HMBC spectra, in CDCl3 as solvent and TMS as internal reference. Chemical shifts in δ (ppm) and coupling constants (J, in parenthesis) in
Hz.
C
O
1
2
3
4
5
6
OCH2CH3
OCH3
HO
1 2
(1)
C δC δH
2JCH
3JCH
1 122.59 —
3 146.10 — C-3
4 149.87 —
C=O 166.43 —
CH
2 111.65 7.53 (d), J = 2Hz C-4
5 113.97 6.91 (d), J = 8.2Hz C-4
6 124.07 7.62 (dd), J = 2a n d
8.4Hz
CH2
1  60.78 4.32 (q), J = 7Hz C-4
CH3
2  14.37 1.36 (t), J = 7Hz
OCH3
3 56.05 3.92 (s)C - 3The Scientiﬁc World Journal 5
the second phase, with percentage of inhibition of 89.12%,
suggesting at least in part a possible peripheral mechanism.
The eﬀect of Dc-EtOH on hot-plate response provides
a conﬁrmation of its central eﬀect. In this model, it also
signiﬁcantly increased the latency time at dose of 200mg/kg.
Asthehot-platetestisaspeciﬁccentralantinociceptivetest,it
is possible that the extract exert their eﬀects through central
mechanisms which are then investigated.
In a previous study [27], the essential oil from barks of
Duguetia lanceolata showed antinociceptive and anti-inﬂam-
matory eﬀects and probably the mechanisms(s) involve cen-
tral and peripheric actions. Thus, the genus Duguetia pre-
sents a great potential for the discovery of new molecules
with antinociceptive activity.
5. Conclusions
In conclusion, the results show that Duguetia chrysocarpa
possesses a good antinociceptive potential. The presence of
alkaloids may be related to the eﬀect of this extract as many
alkaloids show properties on the central nervous system. The
isolation of a derivative of benzoic acid also contributes to
the chemotaxonomy of the genus Duguetia. Further stud-
ies will be performed for the isolation of new chemical
constituents of the plant as well as for a better understanding
ofthemechanismofantinociceptiveactivitypresentedbythe
extract.
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